pillbase.ru

Augtyro

Active substance: repotrectinib

repotrectinib

Centralised EU authorisationActive

Marketing holder: Bristol-Myers Squibb Pharma EEIG

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • Augtyro
    CAPSULE · REPOTRECTINIB 40 mg/1
    0003-4040
    E.R. Squibb & Sons, L.L.C.
  • Augtyro
    CAPSULE · REPOTRECTINIB 160 mg/1
    0003-4160
    E.R. Squibb & Sons, L.L.C.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12095-823f-79db-a907-ff3bb58e2ac0,01a1209a-c7bc-7576-b6c9-2ac76cedfde6;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/006005
Registration status
Active
ATC code
L01EX28
Sources
  • product · EMA · EMEA/H/C/006005 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/006005 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/006005 · Verified 2026-10-09